Polpharma Selects IQVIA Orchestrated Customer Engagement Platform To Improve Salesforce Productivity

IQVIA, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, announced that Polpharma Group BV, a leading Pharmaceutical Company in Rx and OTC medications, has selected IQVIA’s Orchestrated Customer Engagement (OCE) platform to deploy in 12 countries in Central and Eastern Europe, including Poland and Russia.

Recommended AI News: PortAventura World Becomes the First Theme Resort to Accept Bitcoin as Payment at the Hotels Next Season

Markus Sieger, CEO of Polpharma Group stated, “This investment is a part of Polpharma’s 2021-2025 growth strategy and will be key to helping Polpharma Group address the changes in the market and streamline our commercial operations while creating more impactful customer interactions.”

IQVIA OCE provides life science companies full visibility and understanding of their customer interactions and helps them connect with customers across all channels. OCE also drives improved productivity through the automation of administrative and repetitive tasks with its artificial intelligence and machine learning (AI/ML) capabilities. OCE will allow Polpharma to improve salesforce productivity and speed rollout of multi-channel digital marketing campaigns to clients.

“We are proud to support Polpharma Group in their transformation to a new customer engagement model,” said Alistair Grenfell, president Europe, Middle East, Africa and South Asia IQVIA. “The OCE solution will help Polpharma strengthen its market position and deliver a superior, orchestrated customer experience, providing more value to patients and customers.”

Recommended AI News: Seeing Machines unveils its Occula NPU

[To share your insights with us, please write to sghosh@martechseries.com]